# Cooper Companies Moat

Status: published. Policy: company-analysis-1.

Cooper has existing regulatory clearances, intellectual property and technical know-how, but the passages do not establish a durable advantage over established competitors. Organic growth and consumables demand support an operating franchise without proving customer lock-in or superior costs. Pricing power remains unproven: competitive pressure and customer contract structures constrain discretion, while realized price changes are undisclosed. CooperSurgical's recall, litigation expense and product exits demonstrate operational vulnerability. These findings establish neither a positive moat nor the absence of one.

## intangible_assets

Existing device clearances, patents, trademarks and technical know-how are potential sources of protection. Their existence is disclosed; their effectiveness in sustaining an economic advantage over established competitors is not demonstrated.

Durability: PMA development and review can take several years, creating entry friction for relevant devices. However, the portfolio also includes devices cleared through 510(k), most CooperSurgical products are Class II, and patent scope, expiration dates and protected revenue are undisclosed.

Risks: Established competitors already participate in the market. Innovation can undermine differentiation, and regulatory obligations also burden incumbents. The embryo culture media recall and litigation expense are realized operational harm; broader customer losses or market-share erosion are not demonstrated.

Invalidation: The protection thesis would weaken if important patents expired or were invalidated without replacements, clearances were withdrawn, or competing approved products caused sustained customer losses or price concessions. A positive moat assessment would require evidence connecting these assets to persistent customer preference, switching friction or a defensible competitive lead.

Competitors: Johnson & Johnson Vision Care, Inc., Alcon Inc., Bausch + Lomb
- [https://www.sec.gov/Archives/edgar/data/711404/000162828025055615/coo-20251031.htm](https://www.sec.gov/Archives/edgar/data/711404/000162828025055615/coo-20251031.htm) · 2025-12-05
- [https://www.sec.gov/Archives/edgar/data/711404/000162828026061160/coo-20260731.htm](https://www.sec.gov/Archives/edgar/data/711404/000162828026061160/coo-20260731.htm) · 2026-09-09
- [https://www.sec.gov/Archives/edgar/data/711404/000162828026011110/coo-20260224.htm](https://www.sec.gov/Archives/edgar/data/711404/000162828026011110/coo-20260224.htm) · 2026-02-24
- [https://www.sec.gov/Archives/edgar/data/711404/000071140424000074/coo-20241031.htm](https://www.sec.gov/Archives/edgar/data/711404/000071140424000074/coo-20241031.htm) · 2024-12-06
- [https://www.sec.gov/Archives/edgar/data/711404/000071140423000072/coo-20231031.htm](https://www.sec.gov/Archives/edgar/data/711404/000071140423000072/coo-20231031.htm) · 2023-12-08
- [https://www.sec.gov/Archives/edgar/data/711404/000162828026041305/coo-20260430.htm](https://www.sec.gov/Archives/edgar/data/711404/000162828026041305/coo-20260430.htm) · 2026-06-05

[JSON](https://beanvest.com/stock/coo/moat.json)